Mindmedicinelaw

Published October 21, 2026

Optimi Health's MDMA Production Milestone: Phase 3 PTSD - The Psychedelic Journal

Read the full story at Mindmedicinelaw

Optimi Health has finalized GMP-grade MDMA manufacturing for a Phase 3 PTSD trial, addressing key supply and regulatory hurdles.